Trial intelligence / Profile preview

Prophylactic Antibiotics for Hand Lacerations Involving Tendons

NCT01899781Phase 4Completed

Sponsor
Emek Medical Center
Start
Aug 2013
Primary completion
Jan 2015
Modality
Reversible Covalent Inhibitors
01

Overview

A Phase 4 trial of cefazolin in Wound infection (WI), sponsored by Emek Medical Center. Started Aug 2013; status: completed.

02

Drugs

cefazolin
03

Conditions

Wound infection (WI)

Beyond the preview

Go deeper on NCT01899781.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01899781.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call